Search bioRxiv⌕ Search

Biology subjects

Ke, T.

Publications and source records attributed to Ke, T..

3 recordsLinked to original sources

C. elegans CED-1 acts in neurons to modulate ciliary protein abundance and extracellular vesicle shedding

The C. elegans receptor CED-1, along with orthologs mammalian MEGF10 and Drosophila Draper, plays a well-established and conserved role in phagocytosis by acting in engulfing cells.1-7 Interestingly, CED-1 family members are also expressed in neurons, but their functions in these non-engulfing cells remain unclear.6,8,9 Our study shows that CED-1 localizes to the dendrites and primary cilia of male tail RnB neurons, which mediate sensory perceptions during mating10 and generate extracellular vesicles (EVs) that transfer bioactive macromolecules for both intercellular and animal-to-animal communication.11 Loss of ced-1 leads to a reduction in the shedding of EVs that contain the transient receptor potential (TRP) channel PKD-2 from the cilium distal tip, and this is rescued by the expression of CED-1 in the neurons. CED-1 is required to increase both the abundance of PKD-2 in the cilium and PKD-2 EV shedding in response to the physiological stimulus of mating partners. Assessment of ced-1 mutant male mating indicates that neuronal CED-1 is also important for turning behavior, which helps the male tail to maintain contact with a mate. Collectively, these results reveal a new role for CED-1 in neurons as a regulator of EV biogenesis in response to environmental cues, optimizing the shedding of bioactive EVs for effective communication.

cell biology↗

BTBD9 is a novel component of IGF signaling and regulates manganese-induced dopaminergic dysfunction

Restless legs syndrome (RLS) is a common neurological disorder associated with iron deficiency and dopaminergic (DAergic) neuronal dysfunction. BTBD9 is a genetic risk factor for RLS. However, its molecular function remains largely unknown. Here, we report the interaction between BTBD9, manganese (Mn) and insulin/insulin-like growth factor (IGF) signaling in Caenorhabditis elegans, mouse Neuro2a cells and humans. We found that elevated Mn downregulated BTBD9 mRNA levels; in turn, BTBD9 expression attenuated Mn-induced cellular stress and dopaminergic neurodegeneration. As Mn is a known co-factor for insulin receptor and IGF-1 receptor, which activates IGF signaling, we posited that BTBD9 negatively regulates IGF signaling. Our results showed that the protective effects of BTBD9 against Mn toxicity were dependent on the forkhead box O (FOXO) protein. Furthermore, BTBD9 overexpression significantly elevated FOXO level and decreased PKB level, while phosphoinositide-dependent kinase-1 (PDK1) level remained unchanged. We conclude that BTBD9 acts as a key component in the IGF signaling pathway. Meanwhile, the roles of Mn in DAergic neurotoxicity and regulating BTBD9 shed new light on the etiology of RLS.

neuroscience↗

Human H-ferritin presenting RBM of spike glycoprotein as potential vaccine of SARS-CoV-2

The outbreak of COVID-19 has so far inflicted millions of people all around the world and will have a long lasting effect on every aspect of everyones life. Yet there is no effective approved treatment for the disease. In an effort of utilizing human ferritin as nanoplatform for drug delivery, we engineered a fusion protein by presenting receptor-binding motif (RBM) of SARS-CoV-2 virus spike glycoprotein on the N-terminus of ferritin subunits. The designed fusion protein with a cage-like structure, similar to that of corona virus, is a potential anti-SARS-CoV-2 vaccine. We hereby show the construction, preparation, and characterization of the fusion protein RBM-HFtn. Our initial affinity study confirmed its biological activity towards ACE2 receptor which suggests its mode of action against SARS-CoV-2 could be either through vaccine therapy or blocking the cellular entry of virus as antagonist of ACE2 receptor.

bioengineering↗